top of page


Galderma agrees $1.5 billion acquisition of ZO Skin Health to expand dermatological skincare portfolio
Galderma has agreed to acquire ZO Skin Health for an enterprise value of $1.5 billion, expanding its physician-dispensed dermatological skincare portfolio.

nuaxia
4 days ago2 min read


FDA approves RHA Redensity Eye as first hyaluronic acid filler specifically indicated for under-eye hollows
The approval provides clinicians with a dedicated injectable treatment for moderate to severe infraorbital hollowing in adults aged 22 years and older, expanding aesthetic treatment options for the under-eye region.

nuaxia
Aug 212 min read
bottom of page